View of current vascular surgery on asymptomatic carotid stenosis

Czech version

Authors: R. Vlachovský; T. Novotný; R. Staffa
Authors‘ workplace: Centrum cévních onemocnění, II. chirurgická klinika LF MU a FN u sv. Anny v Brně
Published in: Rozhl. Chir., 2025, roč. 104, č. 6, s. 252-256.
Category: Review
doi: https://doi.org/10.48095/ccrvch2025252

Overview

In recent years, the significant progress in the outcomes of conservative treatment for patients with asymptomatic carotid stenosis has sparked discussions about the most effective invasive treatment. The necessity of such treatment is still being debated in certain cases. Several studies have already been conducted to find the most appropriate approach for asymptomatic patients with carotid stenosis, while others are still randomizing and awaiting results. A major unanswered question is whether revascularization is more beneficial than intensive conservative treatment, particularly in view of the lower stroke rates achieved in recent years without conventional or endovascular intervention. The long-term goal should be to identify a subset of patients who would benefit from conservative treatment. In this text, we summarize the issue in the context of the results of two recently completed pivotal studies.

Keywords:

carotid endarterectomy – carotid artery stenting – carotid artery stenosis

Sources

1. Reiff T, Eckstein HH, Mansmann U et al. Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trial. Lancet Neurol 2022; 21(10): 877–888. doi: 10.1016/S1474-4422(22)00290-3.

2. Halliday A, Bulbulia R, Bonati LH et al. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy. Lancet 2021; 398(10305): 1065–1073. doi: 10.1016/S0140-6736(21)01910-3.

3. Roubin GS, Iyer S, Halkin A et al. Realizing the potential of carotid artery stenting: proposed paradigms for patient selection and procedural technique. Circulation 2006; 113(16): 2021–2030. doi: 10.1161/ CIRCULATIONAHA.105.595512.

4. Cremonesi A, Castriota F, Secco GG et al. Carotid artery stenting: an update. Eur Heart J 2015; 36(1): 13–21. doi: 10.1093/ eurheartj/ehu446.

5. Aronow HD, Collins TJ, Gray WA et al. SCAI/SVM expert consensus statement on carotid stenting: training and credentialing for carotid stenting. Catheter Cardiovasc Interv 2016; 87(2): 188–199. doi: 10.1002/ccd.26304.

6. Walker MD, Marler JR, Goldstein M et al. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273(18): 1421–1428. doi: 10.1001/jama.1995.03520420037035.

7. Casana R, Bissacco D, Malloggi C et al. Aortic arch types and postoperative outcomes after carotid artery stenting in asymptomatic and symptomatic patients. Int Angiol 2020; 39(6): 485–491. doi: 10.23736/S0392-9590.20.04494-6.

8. Goode SD, Hoggard N, Macdonald S et al. Assessment of reverse flow as a means of cerebral protection during carotid artery stent placement with diffusion-weighted and transcranial Doppler imaging. J Vasc Interv Radiol 2013; 24(4): 528–533. doi: 10.1016/j.jvir.2012.12.014.

9. Kashyap VS, Schneider PA, Foteh M et al. Early outcomes in the ROADSTER 2 study of transcarotid artery revascularization in patients with significant carotid artery disease. Stroke 2020; 51(9): 2620–2629. doi: 10.1161/STROKEAHA.120.030550.

10. Kelly MP, Heath I, Howick J et al. The importance of values in evidence-based medicine. BMC Med Ethics 2015; 16(1): 69. doi: 10.1186/s12910-015-0063-3.

11. White CJ. Carotid artery stenting. J Am Coll Cardiol 2014; 64(7): 722–731. doi: 10.1016/j.jacc.2014.04.069.

12. Turan TN, Voeks JH, Chimowitz MI et al. Rationale, design, and implementation of intensive risk factor treatment in the CREST2 trial. Stroke 2020; 51(10): 2960–2971. doi: 10.1161/STROKEAHA.120.030730.

13. Howard DP, Gaziano L, Rothwell PM. Risk of stroke in relation to degree of asymptomatic carotid stenosis: a populationbased cohort study, systematic review, and meta-analysis. Lancet Neurol 2021; 20(3): 193–202. doi: 10.1016/S1474 4422(20)30484-1.

14. Naylor R, Rantner B, Ancetti S et al. Editor‘s choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. Eur J Vasc Endovasc Surg 2023; 65(1): 7–111. doi: 10.1016/j.ejvs.2022.04.011.

15. Kamtchum-Tatuene J, Noubiap JJ, Wilman AH et al. Prevalence of high-risk plaques and risk of stroke in patients with asymptomatic carotid stenosis: a meta-analysis. JAMA Neurol 2020; 77(12): 1524–1535. doi: 10.1001/jamaneurol.2020.2658.

16. Halliday A, Mansfield A, Marro J et al. MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004; 363(9420): 1491–1502. doi: 10.1016/S0140-6736(04)16146-1.

17. Lazar RM, Wadley VG, Myers T et al. Baseline cognitive impairment in patients with asymptomatic carotid stenosis in the CREST-2 trial. Stroke 2021; 52(12): 3855–3863. doi: 10.1161/STROKEAHA.120.032972.

18. Marshall RS, Lazar RM, Liebeskind DS et al. Carotid revascularization and medical management for asymptomatic carotid stenosis – hemodynamics (CRESTH): study design and rationale. Int J Stroke 2018; 13(9): 985–991. doi: 10.1177/1747493018790088.

19. Abbott AL, Silvestrini M, Topakian R et al. Optimizing the definitions of stroke, transient ischemic attack, and infarction for research and application in clinical practice. Front Neurol 2017; 8: 537. doi: 10.3389/fneur.2017.00537.

20. Přibáň V, Fiedler J, Chlouba V et al. Simultaneous carotid endarterectomy and coronary revascularization: indications and results. Rozhl Chir 2011; 90(1): 67–72.